These data are evidence that the enzymes CYP1A2 and CYP1B1 are implicated in the pathogenesis of age-related macular-degeneration-like retinopathy in OXYS rats and are possible therapeutic targets of SkQ1 [266]. The gene discussed is CYP1B1; the disease is retinal disorder.